Severe PPH (≥ 1000 mL) · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
It is very uncertain whether active changes severe primary PPH (clinically estimated or measured blood loss ≥… compared with expectant management of the third stage of labour (all women) (very low certainty).
1 finding from 1 review
Very severe primary PPH (clinically estimated or measured blood loss ≥ to 2500 mL at time of birth) · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Maternal death · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Maternal Hb < 9 g/dL 24‐72 hours postpartum · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
Active may leads to lower maternal Hb < 9 g/dL 24‐72 hours postpartum compared with expectant management of the third stage of labour (all women) (low certainty).
1 finding from 1 review
Admission to SCBU/NICU · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
Active showed no clear difference in admission to SCBU/NICU compared with expectant management of the third stage of labour (all women) (low certainty).
1 finding from 1 review
Neonatal jaundice requiring phototherapy or exchange transfusion · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
It is very uncertain whether active changes neonatal jaundice requiring phototherapy or exchange transfusion compared with expectant management of the third stage of labour (all women) (very low certainty).
1 finding from 1 review
Neonatal polycythaemia treated with dilutional exchange transfusion · all women who expected a vaginal birth at 24 weeks' gestation or later and their babies
1 finding from 1 review
Change in use of topical active treatment ‐ not measured · people with eczema
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events: active lotion vs placebo · individuals at risk of pressure ulcer development
It is very uncertain whether active topical agent changes adverse events: active lotion vs placebo compared with placebo/control (very low certainty).
1 finding from 1 review
Proportion of participants developing a new pressure ulcer · individuals at risk of pressure ulcer development
It is very uncertain whether active topical agent changes pressure ulcer incidence: active lotion vs placebo compared with placebo/control (very low certainty).
2 findings from 1 review
All outcomes ‐ not measured · stroke survivors and their carers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants developing a new pressure ulcer · pressure ulcer prevention
It is very uncertain whether reactive air surfaces changes proportion of participants developing a new pressure ulcer compared with alternating pressure (active) air surfaces (very low certainty).
1 finding from 1 review
Proportion of participants developing a new pressure ulcer · pressure ulcer prevention
It is very uncertain whether reactive air surfaces changes proportion of participants developing a new pressure ulcer compared with reactive water surfaces (very low certainty).
1 finding from 1 review
Time to pressure ulcer development · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Support surface associated patient comfort · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All reported adverse events · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness · pressure ulcer prevention
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants developing a new pressure ulcer · pressure ulcer prevention
It is very uncertain whether reactive air surfaces changes proportion of participants developing a new pressure ulcer compared with reactive gel surfaces (very low certainty).
1 finding from 1 review
Time to pressure ulcer development · pressure ulcer prevention
Reactive air surfaces may leads to lower time to pressure ulcer incidence compared with alternating pressure (active) air surfaces (low certainty).
1 finding from 1 review